Thu-26-11-2020, 13:55 PM
Update: Approval has now gone through for the treatment of adult patients with active psoriatic arthritis (PsA) who have had an inadequate response or who have been intolerant to a prior disease-modifying antirheumatic drug (DMARD) therapy.